Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 00071188 AND DT 2014 AND VI 171 AND IP 21
Results: 24
1
2
PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate.
- Published in:
- 2014
- By:
- Publication type:
- journal article
4
(4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
5
Multiple roles of the PGE2 -EP receptor signal in vascular permeability.
- Published in:
- 2014
- By:
- Publication type:
- journal article
6
Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway.
- Published in:
- 2014
- By:
- Publication type:
- journal article
7
Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists.
- Published in:
- 2014
- By:
- Publication type:
- journal article
8
A novel 1,2-benzenediamine derivative FC-99 suppresses TLR3 expression and ameliorates disease symptoms in a mouse model of sepsis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
9
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals.
- Published in:
- 2014
- By:
- Publication type:
- journal article
10
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4850, doi. 10.1111/bph.12793
- By:
- Publication type:
- Article
11
A novel 1,2-benzenediamine derivative FC-99 suppresses TLR3 expression and ameliorates disease symptoms in a mouse model of sepsis.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4866, doi. 10.1111/bph.12797
- By:
- Publication type:
- Article
12
Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4808, doi. 10.1111/bph.12554
- By:
- Publication type:
- Article
13
Investigating the molecular mechanisms through which FTY720- P causes persistent S1P<sub>1</sub> receptor internalization.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4797, doi. 10.1111/bph.12620
- By:
- Publication type:
- Article
14
Evaluation of peripheral versus central effects of GABA<sub>B</sub> receptor activation using a novel, positive allosteric modulator of the GABA<sub>B</sub> receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4941, doi. 10.1111/bph.12812
- By:
- Publication type:
- Article
15
Pharmacologically distinct phenotypes of α<sub>1B</sub>-adrenoceptors: variation in binding and functional affinities for antagonists.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4890, doi. 10.1111/bph.12813
- By:
- Publication type:
- Article
16
Multiple roles of the PGE<sub>2</sub>- EP receptor signal in vascular permeability.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4879, doi. 10.1111/bph.12815
- By:
- Publication type:
- Article
17
Lipoxin A<sub>4</sub> suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4927, doi. 10.1111/bph.12816
- By:
- Publication type:
- Article
18
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3- O-phosphate.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4902, doi. 10.1111/bph.12817
- By:
- Publication type:
- Article
19
Small-molecule modulators of the OX40- OX40 ligand co-stimulatory protein-protein interaction.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4955, doi. 10.1111/bph.12819
- By:
- Publication type:
- Article
20
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4820, doi. 10.1111/bph.12590
- By:
- Publication type:
- Article
21
Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del- CFTR by a CDK-independent mechanism.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4831, doi. 10.1111/bph.12859
- By:
- Publication type:
- Article
22
(4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4970, doi. 10.1111/bph.12821
- By:
- Publication type:
- Article
23
PKC inhibition results in a K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 pharmacology closer to K<sub>v</sub>1.5 channels.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. 4914, doi. 10.1111/bph.12822
- By:
- Publication type:
- Article
24
Issue Information.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 21, p. i, doi. 10.1111/bph.12390
- Publication type:
- Article